Once-daily SYMTUZA is a complete prescription HIV treatment regimen in one pill. SYMTUZA contains darunavir, which can help you keep fighting HIV with its high barrier to HIV drug resistance. Darunavir can help stop HIV from replicating.

Resources

Dr. Moti Ramgopal & Dr. Joseph Gathe, Investigators of the DIAMOND study review data from the first Phase 3 clinical trial for a single-tablet regimen where patients rapidly started treatment, as well as a real patient story from the DIAMOND clinical trial. https://www.symtuzahcp.com/peer-perspectives/agent-of-change

Dr. Douglas Cunningham, Investigator of the EMERALD study reviews Week 48 data. https://www.symtuzahcp.com/peer-perspectives/real-people

Dr. Matt Birnholz & Dr. Jason M. Leider explore how you can help manage HIV-1 in treatment-naive patients - even before resistance test results are known - in this SYMTUZA product discussion. https://www.symtuzahcp.com/peer-perspectives/no-medical-records-guidelines

For more information, please contact your local Janssen Representative: